title: Antagonist antibodies to PD-1 and B7-H1 (PD-L1) in the treatment of advanced human cancer--letter.
authors.affiliation: Authors' Affiliations: Department of Melanoma Medical Oncology, University of Texas, MD Anderson Cancer Center, Houston, Texas; and Cutaneous Oncology Department, H. Lee Moffitt Cancer Center and Research Institute, Tampa, Florida.
authors.forename: Laszlo
authors.initials: L
authors.lastname: Radvanyi
authors.forename: Shari
authors.initials: S
authors.lastname: Pilon-Thomas
authors.forename: Weiyi
authors.initials: W
authors.lastname: Peng
authors.forename: Amod
authors.initials: A
authors.lastname: Sarnaik
authors.forename: James J
authors.initials: JJ
authors.lastname: Mulé
authors.forename: Jeffrey
authors.initials: J
authors.lastname: Weber
authors.forename: Patrick
authors.initials: P
authors.lastname: Hwu
mesh_terms: D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D060890:B7-H1 Antigen / Q000037:antagonists & inhibitors*; D006801:Humans; D009369:Neoplasms / Q000628:therapy*; D061026:Programmed Cell Death 1 Receptor / Q000037:antagonists & inhibitors*
chemical_list: D000911:Antibodies, Monoclonal; D060890:B7-H1 Antigen; D061026:Programmed Cell Death 1 Receptor
references.citation: Cancer Res. 2012 Oct 15;72(20):5209-18
references.pmid: 22915761
references.citation: Clin Cancer Res. 2013 Mar 1;19(5):1021-34
references.pmid: 23460533
references.citation: J Immunol. 2013 May 1;190(9):4899-909
references.pmid: 23536636
references.citation: J Immunol. 2010 Apr 1;184(7):3442-9
references.pmid: 20194714
references.citation: Clin Cancer Res. 2012 Dec 15;18(24):6758-70
references.pmid: 23032743